Novartis AG
(NYSE:NVS)
$96.30
0.37 (0.39%)
At Close: 4:00 PM
NVS Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
NVS Stock Price Today
Novartis AG (NVS) stock declined over -0.75% intraday to trade at $96.325 a share on NYSE. The stock opened with a loss of -1.93% at $94.08 and touched an intraday high of $94.16, rising 0.41% against the last close of $95.93. The Novartis AG in stock market went to a low of $92.19 during the session.
NVS Stock Snapshot
$95.93
Prev. Close
191.96 Billion
Market Cap
$92.19
Day Low
$94.08
Open
N/A
Number of Shares
$94.16
Day High
25.92
P/E ratio
3.72
EPS (TTM)
6.24
Cash Flow per Share
N/A
Free Float in %
18.57
Book Value
3222954.00
Volume
NVS Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta0.55
Sales or Revenue$54.22 Billion
5Y Sales Change0.74%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryDrug Manufacturers—General
About Company
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Peers
Frequently Asked Questions
What is the current Novartis AG (NVS) stock price?
Novartis AG (NYSE: NVS) stock price is $96.33 in the last trading session. During the trading session, NVS stock reached the peak price of $94.16 while $92.19 was the lowest point it dropped to. The percentage change in NVS stock occurred in the recent session was -0.75% while the dollar amount for the price change in NVS stock was -$0.72.
NVS's industry and sector of operation?
The NYSE listed NVS is part of Drug Manufacturers—General industry that operates in the broader Healthcare sector. Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz.
Who are the executives of NVS?
Paul Penepent
Head of Group Financial Reporting and Accounting
Dr. Samir Shah M.D.
Global Head of Investor Relations
Mr. Richard Saynor
Chief Executive Officer of Sandoz
Ms. Marie-France Tschudin
Pres of Innovative Medicines International & Chief Commercial Officer
How NVS did perform over past 52-week?
NVS's closing price is 0.41% higher than its 52-week low of $79.66 where as its distance from 52-week high of $105.61 is -0.01%.
How many employees does NVS have?
Number of NVS employees currently stands at N/A. NVS operates from Lichtstrasse 35, Basel, 4056, CH.
Link for NVS official website?
Official Website of NVS is: https://www.novartis.com
How do I contact NVS?
NVS could be contacted at phone #41 61 324 1111 and can also be accessed through its website. NVS operates from Lichtstrasse 35, Basel, 4056, CH.
How many shares of NVS are traded daily?
NVS stock volume for the day was 3222954.00 shares. The average number of NVS shares traded daily for last 3 months was 1.57 Million.
What is the market cap of NVS currently?
The market value of NVS currently stands at $191.96 Billion with its latest stock price at $96.33 and N/A of its shares outstanding.